Correction to: Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany
Orphanet J Rare Dis
.
2022 Oct 25;17(1):387.
doi: 10.1186/s13023-022-02548-7.
Authors
Andreas Hahn
1
,
René Günther
2
,
Albert Ludolph
3
,
Oliver Schwartz
4
,
Regina Trollmann
5
,
Patrick Weydt
6
,
Markus Weiler
7
,
Kathrin Neuland
8
,
Martin Sebastian Schwaderer
8
,
Tim Hagenacker
9
;
Risdiplam Compassionate Use Program Group
Affiliations
1
Department of Child Neurology, University of Gießen, Giessen, Germany.
2
Department of Neurology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
3
Department of Neurology, University of Ulm, Ulm, Germany.
4
Department of Pediatric Neurology, Münster University Hospital, Münster, Germany.
5
Division of Pediatric Neurology, Department of Pediatrics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
6
Department of Neurodegenerative Diseases and Gerontopsychiatry/Neurology, University of Bonn Medical Center, Bonn, Germany.
7
Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.
8
Roche Pharma AG, Grenzach-Wyhlen, Germany.
9
Department of Neurology, University Hospital Essen, Essen, Germany.
[email protected]
.
PMID:
36284315
PMCID:
PMC9597989
DOI:
10.1186/s13023-022-02548-7
No abstract available
Publication types
Published Erratum